Trials / Unknown
UnknownNCT04673695
A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344
An Open Label, Randomized, Single-dose, 2-sequence, 2-period, Cross-over Phase 1 Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Adult Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A Clinical Trial to evaluate the Pharmacokinetics and safety of CKD-344
Detailed description
A Phase 1 Clinical Trial to evaluate the safety and pharmacokinetics in healthy adult volunteers after administration of CKD-344.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lixiana(D006) | NOAC(Factor Xa inhibitor) |
| DRUG | CKD-344 | NOAC(Factor Xa inhibitor) |
Timeline
- Start date
- 2020-11-13
- Primary completion
- 2020-12-26
- Completion
- 2021-01-02
- First posted
- 2020-12-17
- Last updated
- 2020-12-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04673695. Inclusion in this directory is not an endorsement.